预测机器人辅助根治性前列腺切除术后功能结局的新工具及失禁额外手术的价值
本研究基于比利时25个中心9421例患者的前瞻性数据,开发并验证了预测机器人辅助根治性前列腺切除术后12个月控尿状态的模型。模型利用术前和术后3个月数据,通过列线图和在线工具可视化,有助于个体化咨询患者尿失禁风险并选择最佳治疗方案。
要点
- 术前模型可个体化预测RARP术后12个月尿失禁风险。
- 术后3个月模型可识别保守治疗获益可能性低的患者。
- 模型有助于咨询患者是否需要控尿手术。
核心结论
- 模型为更准确的患者咨询奠定了基础,术前模型评估尿失禁风险,术后模型识别可能无需保守治疗而应咨询控尿手术的患者。
研究设计与样本
- 前瞻性收集2009-2016年比利时25个中心9421例患者的数据,使用线性回归收缩评估术前和术后3个月特征与12个月控尿状态的关联。
主要发现
- 12个月时ICIQ-UI-SF平均得分为4.3(标准差4.7),是术前平均得分1.4的三倍。
- 术前模型中,高EAU生化复发风险分类(估计值0.606,标准误0.165)、术后放疗(估计值1.563,标准误0.641)、较低的术前EORTC QLQ-C30/QoL评分(估计值-0.011,标准误0.003)、较高的术前ICIQ-UI-SF评分(估计值0.214,标准误0.018)和年龄较大(估计值0.058,标准误0.009)与较高的12个月ICIQ-UI-SF评分相关。
- 3个月模型中,较高的术前ICIQ-UI-SF评分(估计值0.083,标准误0.014)、年龄较大(估计值0.024,标准误0.007)、较低的3个月EORTC QLQ-C30/QoL评分(估计值-0.010,标准误0.002)和较高的3个月ICIQ-UI-SF评分(估计值0.562,标准误0.009)与较高的12个月ICIQ-UI-SF评分相关。
临床怎么用
- 利用术前模型个体化咨询患者RARP术后尿失禁风险以选择最佳治疗。
- 利用术后3个月模型识别保守治疗获益可能性低的患者并咨询控尿手术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop and validate a model to predict 12-month continence status after robot-assisted radical prostatectomy (RARP) from preoperative and 3-month postoperative data; this model could help in informing patients on their individualised risk of urinary incontinence (UI) after RP in order to choose the best treatment option. PATIENTS AND METHODS: Data on 9421 patients in 25 Belgian centres were prospectively collected (2009-2016) in a compulsory regional database. The primary outcome was the prediction of continence status, using the International Consultation on Incontinence Urinary Incontinence Short Form (ICIQ-UI-SF) at 12-months after RARP. Linear regression shrinkage was used to assess the association between preoperative 3-month postoperative characteristics and 12-month continence status. This association was visualised using nomograms and an online tool. RESULTS: At 12 months, the mean (sd) score of the ICIQ-UI-SF questionnaire was 4.3 (4.7), threefold higher than the mean preoperative score of 1.4. For the preoperative model, high European Association of Urology risk classification for biochemical recurrence (estimate [Est.] 0.606, se 0.165), postoperative radiotherapy (Est. 1.563, se 0.641), lower preoperative European Organisation for Research and Treatment of Cancer quality of life questionnaire 30-item core (EORCT QLQ-C30)/quality of life (QoL) score (Est. -0.011, se 0.003), higher preoperative ICIQ-UI-SF score (Est 0.214, se 0.018), and older age (Est. 0.058, se 0.009), were associated with a higher 12-month ICIQ-UI-SF score. For the 3-month model, higher preoperative ICIQ-UI-SF score (Est. 0.083, se 0.014), older age (Est. 0.024, se 0.007), lower 3-month EORCT QLQ-C30/QoL score (Est. -0.010, se 0.002) and higher 3-month ICIQ-UI-SF score (Est. 0.562, se 0.009) were associated with a higher 12-month ICIQ-UI-SF score. CONCLUSIONS: Our models set the stage for a more accurate counselling of patients. In particular, our preoperative model assesses the risk of UI according to preoperative and early postoperative variables. Our postoperative model can identify patients who most likely would not benefit from conservative treatment and should be counselled on continence surgery.
引用
- Tutolo M, Bruyneel L, Van der Aa F, et al. A novel tool to predict functional outcomes after robot-assisted radical prostatectomy and the value of additional surgery for incontinence. BJU Int. 2020. PMID: 32929874. doi:10.1111/bju.15242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。